In humans, an elevated FGF21 level in HF patients may be indicative of a FGF21-resistant state in response to chronic cardiac stress, as has been proposed in obesity [70], or a compensatory response to comorbid metabolic conditions, such as diabetes, which can precipitate HF [21]. The gene discussed is FGF21; the disease is Obesity.